• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Obseva SA News

    0,0064 CHF -11,11% -0,0008 CHF
    In : 0,0065 € | 30.04.24 17:31:59 SIX Swiss Exchange aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EELW
    ISIN: CH1260041939
    US-Symbol: OBSEF
    Typ: Aktie

    Obseva SA News

    20.04.23 - GlobeNewswire
    ObsEva Announces Change of Central Securities Depositary
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    31.03.23 - GlobeNewswire
    ObsEva Files Year End 2022 Financial Statements
    ObsEva Files Year End 2022 Financial Statements
    15.03.23 - GlobeNewswire
    ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    13.03.23 - GlobeNewswire
    ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    06.03.23 - PR Newswire
    Thinking about buying stock in Mullen Automotive, Snap, Meta Platforms, Obseva SA, or Ambrx Biopharma?
    Thinking about buying stock in Mullen Automotive, Snap, Meta Platforms, Obseva SA, or Ambrx Biopharma? PR Newswire
    24.02.23 - GlobeNewswire
    ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    19.12.22 - GlobeNewswire
    ObsEva Announces Dismissal of Moratorium Proceedings
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    14.12.22 - GlobeNewswire
    ObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    09.12.22 - GlobeNewswire
    ObsEva To Increase Issued Share Capital by Creating Additional Treasury Shares
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    01.12.22 - GlobeNewswire
    ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    22.11.22 - PR Newswire
    Thinking about buying stock in Obseva SA, Cosmos Holdings, Alibaba, American Eagle Outfitters, or TJX Companies?
    Thinking about buying stock in Obseva SA, Cosmos Holdings, Alibaba, American Eagle Outfitters, or TJX Companies? PR Newswire
    22.11.22 - GlobeNewswire
    ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
    Sale of Ebopiprant royalty and milestone license to XOMA includes upfront payment of $15 million and future milestone payments of up to $98 million The sale proceeds are ...
    26.10.22 - GlobeNewswire
    ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
    Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $ 1 6.0 million savings expected from assignment of program contracts, ...
    13.10.22 - GlobeNewswire
    ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    13.09.22 - GlobeNewswire
    ObsEva Announces Progress on Restructuring Initiatives
    $7.6 million annual savings expected via re duction -in-force currently underway $6.2 million savings expected from assignment of l egacy linzagolix program contracts to Kissei ...
    22.08.22 - GlobeNewswire
    ObsEva Receives Nasdaq Non-Compliance Notice
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    17.08.22 - GlobeNewswire
    ObsEva Files Second Quarter 2022 Financial Statements
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    01.08.22 - GlobeNewswire
    ObsEva Announces $31 million Debt Retirement and $11 million Debt Refinancing
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – August 1, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN) , a biopharmaceutical ...
    29.07.22 - GlobeNewswire
    ObsEva Announces Management Change
    Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
    27.07.22 - PR Newswire
    Thinking about buying stock in Shopify, Obseva SA, Vistagen Therapeutics, SIGA Technologies, or Exela Technologies?
    Thinking about buying stock in Shopify, Obseva SA, Vistagen Therapeutics, SIGA Technologies, or Exela Technologies? PR Newswire

    Newssuche

    Videos

    newspaper
    30.04.24 -9,41%
    Technical Trading: Sojabohnen Long bis Juli
    Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »